GB9805477D0 - Methods and compositions for diagnosis of rheumatoid arthritis - Google Patents

Methods and compositions for diagnosis of rheumatoid arthritis

Info

Publication number
GB9805477D0
GB9805477D0 GBGB9805477.8A GB9805477A GB9805477D0 GB 9805477 D0 GB9805477 D0 GB 9805477D0 GB 9805477 A GB9805477 A GB 9805477A GB 9805477 D0 GB9805477 D0 GB 9805477D0
Authority
GB
United Kingdom
Prior art keywords
diagnosis
compositions
methods
rheumatoid arthritis
rheumatoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9805477.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Priority to GBGB9805477.8A priority Critical patent/GB9805477D0/en
Publication of GB9805477D0 publication Critical patent/GB9805477D0/en
Priority to CN99806001A priority patent/CN1300367A/en
Priority to PCT/GB1999/000763 priority patent/WO1999047925A2/en
Priority to AU29429/99A priority patent/AU756588B2/en
Priority to ZA9902079A priority patent/ZA992079B/en
Priority to EP99910490A priority patent/EP1062509A2/en
Priority to CA002323238A priority patent/CA2323238A1/en
Priority to JP2000537069A priority patent/JP2002507723A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Rehabilitation Therapy (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB9805477.8A 1998-03-13 1998-03-13 Methods and compositions for diagnosis of rheumatoid arthritis Ceased GB9805477D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB9805477.8A GB9805477D0 (en) 1998-03-13 1998-03-13 Methods and compositions for diagnosis of rheumatoid arthritis
CN99806001A CN1300367A (en) 1998-03-13 1999-03-15 Methods and compositions for diagnosis of rheumatoid arthritis
PCT/GB1999/000763 WO1999047925A2 (en) 1998-03-13 1999-03-15 Methods and compositions for diagnosis of rheumatoid arthritis
AU29429/99A AU756588B2 (en) 1998-03-13 1999-03-15 Methods and compositions for diagnosis of rheumatoid arthritis
ZA9902079A ZA992079B (en) 1998-03-13 1999-03-15 Methods and compositions for diagnosis of rheumatoid arthritis.
EP99910490A EP1062509A2 (en) 1998-03-13 1999-03-15 Methods and compositions for diagnosis of rheumatoid arthritis
CA002323238A CA2323238A1 (en) 1998-03-13 1999-03-15 Methods and compositions for diagnosis of rheumatoid arthritis
JP2000537069A JP2002507723A (en) 1998-03-13 1999-03-15 Methods and compositions for the diagnosis of rheumatoid arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9805477.8A GB9805477D0 (en) 1998-03-13 1998-03-13 Methods and compositions for diagnosis of rheumatoid arthritis

Publications (1)

Publication Number Publication Date
GB9805477D0 true GB9805477D0 (en) 1998-05-13

Family

ID=10828567

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9805477.8A Ceased GB9805477D0 (en) 1998-03-13 1998-03-13 Methods and compositions for diagnosis of rheumatoid arthritis

Country Status (8)

Country Link
EP (1) EP1062509A2 (en)
JP (1) JP2002507723A (en)
CN (1) CN1300367A (en)
AU (1) AU756588B2 (en)
CA (1) CA2323238A1 (en)
GB (1) GB9805477D0 (en)
WO (1) WO1999047925A2 (en)
ZA (1) ZA992079B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858210B1 (en) * 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
IL153189A0 (en) 2000-06-19 2003-06-24 Correlogic Systems Inc Heuristic method of classification
NZ524171A (en) 2000-07-18 2006-09-29 Correlogic Systems Inc A process for discriminating between biological states based on hidden patterns from biological data
WO2002054079A2 (en) * 2000-10-24 2002-07-11 Oxford Glycosciences (Uk) Limited Proteins, genes and their use for diagnosis and treatment of cardiac response
EP1405072A2 (en) * 2000-12-29 2004-04-07 Oxford GlycoSciences (UK) Limited Proteins, genes and their use for diagnosis and treatment of kidney response
WO2002054080A2 (en) * 2000-12-29 2002-07-11 Oxford Glycosciences (Uk) Ltd. Proteins, genes and their use for diagnosis and treatment of vascular response
DE10127572A1 (en) * 2001-05-30 2002-12-05 Pathoarray Gmbh Tools for the diagnosis, molecular definition and therapy development of chronic inflammatory joint diseases
US20030100016A1 (en) * 2001-11-23 2003-05-29 George Jackowski Complement C3 precursor biopolymer markers predictive of Alzheimers disease
NL1019540C2 (en) * 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Method for detecting autoantibodies from patients suffering from rheumatoid arthritis, peptide and assay kit.
US20030224386A1 (en) * 2001-12-19 2003-12-04 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
US7395160B2 (en) 2002-07-29 2008-07-01 Correlogic Systems, Inc. Quality assurance/quality control for electrospray ionization processes
CN1871362A (en) * 2003-09-05 2006-11-29 皇家妇女医院 Diagnostic marker for ovarian cancer
CA2548842A1 (en) 2003-12-11 2005-07-07 Correlogic Systems, Inc. Method of diagnosing biological states through the use of a centralized, adaptive model, and remote sample processing
WO2009006439A1 (en) 2007-06-29 2009-01-08 Correlogic Systems, Inc. Predictive markers for ovarian cancer
ES2568702B1 (en) * 2014-10-01 2017-02-13 Servizo Galego De Saude (Sergas) METHOD FOR THE DIAGNOSIS OF ARTROSIS
CN106950365B (en) * 2017-02-15 2018-11-27 中国医学科学院北京协和医院 A kind of RA diagnosis marker of ACPA feminine gender and its application
CN108732253A (en) * 2017-04-14 2018-11-02 杭州量康科技有限公司 Peptide fragment composition and assay method for serous proteinquatative measurement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3580882D1 (en) * 1984-09-14 1991-01-24 Asahi Medical Co A PROTEIN SPECIFICALLY PURE FOR RHEUMATOID ARTHRITIS AND AN ANTIBODY AGAINST IT.
EP0378732A1 (en) * 1989-01-20 1990-07-25 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. Serum proteins related to autoimmune disease
US5837686A (en) * 1991-11-25 1998-11-17 Peptide Therapeutics Limited Peptides and antibodies for treatment of rheumatoid arthritis
US5547928A (en) * 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer

Also Published As

Publication number Publication date
WO1999047925A3 (en) 1999-11-25
AU2942999A (en) 1999-10-11
AU756588B2 (en) 2003-01-16
CN1300367A (en) 2001-06-20
EP1062509A2 (en) 2000-12-27
CA2323238A1 (en) 1999-09-23
JP2002507723A (en) 2002-03-12
WO1999047925A2 (en) 1999-09-23
ZA992079B (en) 2000-10-10

Similar Documents

Publication Publication Date Title
AU2002230997A1 (en) Methods and compositions for diagnosing and treating rheumatoid arthritis
GB9805477D0 (en) Methods and compositions for diagnosis of rheumatoid arthritis
GB2340911B (en) Alloy pipes and methods of making same
GB9828109D0 (en) Inspection equipment and methods of inspection
EP1056456A4 (en) R-lansoprazole compositions and methods
PL340010A1 (en) Method of obtaining heterophasal polymeric compositions and compositions obtained thereby
PL339619A1 (en) Compositions containing copolymers of polyphenoles and method of obtaining such compositions
HUP0103563A3 (en) Method of modulating memory effector t-cells and compositions
EP1056457A4 (en) S-lansoprazole compositions and methods
EP1073333A4 (en) S-rabeprazole compositions and methods
PL339731A1 (en) Methods of and compositions for treating rheumatoid arthritis
EP1139981A4 (en) Compositions and methods of using the same
IL137836A0 (en) Methods and compositions for diagnosis of hepatoma
EP1062320A4 (en) Methods and compositions for the selective expansion of gamma/delta t-cells
ZA982338B (en) Method for the diagnosis of rheumatoid arthritis
AU2433100A (en) Methods and compositions for the fixation of trace amounts of radiocaesium
PL344785A1 (en) Methods for increasing levels of acetylcholine
IL138914A0 (en) Methods for increasing levels of acetylcholine
EP1073332A4 (en) R-rabeprazole compositions and methods
EP1100432A4 (en) Novel uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
AU1194600A (en) Method and device for measuring the bone mineral content of the skeleton
SI1021200T1 (en) Methods and compositions for treating rheumatoid arthritis
HUP9903204A3 (en) Method for determenating of space and mass composition element-concentrations in an casting-fibre and aparatus for making this method
AUPP469598A0 (en) Method of and composition for the treatment of rheumatoid arthritis and psoriatic arthritis
GB2333109B (en) Foundations and method of forming the same

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)